WS
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
21.462
Exchange
XNYS - New York Stock Exchange, Inc
2.8
Last period Current ratio
-5%
Current ratio has decreased in 5 years
What is Current ratio ?
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
See also West Pharmaceutical
Company Analysis
WST valuation, rating, competitors, insights and company profile
Eyestock Rating
WST financial analysis by Eyestock methodology
Valuation
WST valuation using historical relative method
Statements
WST Income Statements, Balance Sheet and Cash Flow Statements
Dividends
WST dividend yield and annual dividend
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
West Pharmaceutical`s Current ratio for the last twelve months ended 2024-06-30 is 2.8
